Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Izrael, Tel Awiw
Ofer Merimsky
41 lat doświadczenia
akredytacje :
Akredytacje :
Liver cancer treatment cost in Israel ranges from $22,000 to $40,000 for surgical removal, while essential diagnostics like a PET/CT scan run from $1,300 to $1,800. Total expenses depend on the cancer stage, the use of robotic technology, and the hospital type. International patients typically save 30–80% compared to the United States. Premier care is centered in Tel Aviv, Jerusalem, and Haifa.
Typical Liver Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients seeking high success rates should prioritize JCI-accredited centers like Sourasky Medical Center, which reports a 90% oncology success rate. For those requiring complex GI interventions, Forbes-listed experts like Dr. Menahem Ben-haim offer specialized surgical expertise. Private options like Assuta Medical Center provide the most flexibility, allowing patients to select their specific surgeon and room type for a personalized experience.
| Izrael | Turcja | Austria | |
| Terapia protonowa | od $48,000 | od $70,000 | od $80,000 |
| Resekcja w przypadku raka wątroby | od $22,000 | od $10,800 | od $40,000 |
| Nano-nóż | od $18,500 | od $9,500 | od $25,000 |
| CyberKnife | od $17,500 | od $4,750 | od $50,000 |
| Chemoembolizacja wątroby | od $14,800 | od $7,500 | od $16,000 |
Prof. Merimsky kieruje oddziałem mięsaków w Centrum Medycznym Sourasky. Posiada on głęboką wiedzę specjalistyczną w leczeniu raka wątroby oraz ponad 30-letnie doświadczenie zawodowe.
Dr Pelles Sharon specjalizuje się w zaawansowanych metodach leczenia raka wątroby w Centrum Medycznym Sourasky, w tym w chemioterapii i terapiach celowanych. Aktywnie angażuje się w badania onkologiczne, zapewniając opiekę nad pacjentami opartą na faktach medycznych.
Prof. Arber specjalizuje się w profilaktyce i diagnostyce nowotworów układu pokarmowego, a nie tylko w ich leczeniu. Kieruje Centrum Profilaktyki Nowotworów w Centrum Medycznym Sourasky.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.